Today: Glaukos Corp. (GKOS) Receives $39.20 Consensus Price Target from Analysts

Today: Glaukos Corp. (GKOS) Receives $39.20 Consensus Price Target from Analysts

Shares of Glaukos Corp. (NYSE:GKOS) have earned a consensus rating of “Buy” from the seven analysts that are covering the stock. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $39.20.

Several brokerages have issued reports on GKOS. Zacks Investment Research cut shares of Glaukos Corp. from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. Piper Jaffray Cos. reaffirmed an “overweight” rating and set a $40.00 target price (up previously from $27.00) on shares of Glaukos Corp. in a research note on Monday, August 1st. Roth Capital lifted their target price on shares of Glaukos Corp. from $36.50 to $41.00 and gave the stock a “buy” rating in a research note on Tuesday, August 2nd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $41.00 target price on shares of Glaukos Corp. in a research note on Sunday, September 25th. Finally, Stifel Nicolaus reaffirmed a “hold” rating on shares of Glaukos Corp. in a research note on Tuesday, September 27th.

In other Glaukos Corp. news, CFO Richard L. Harrison sold 10,000 shares of the company’s stock in a transaction dated Wednesday, July 27th. The shares were sold at an average price of $35.01, for a total value of $350,100.00. Following the transaction, the chief financial officer now owns 11,388 shares of the company’s stock, valued at $398,693.88. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Jonathan Silverstein sold 292,938 shares of the company’s stock in a transaction dated Friday, August 12th. The shares were sold at an average price of $33.69, for a total transaction of $9,869,081.22. The disclosure for this sale can be found here. Insiders own 36.80% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of GKOS. Deerfield Management Co. bought a new position in Glaukos Corp. during the second quarter worth approximately $28,697,000. Lord Abbett & CO. LLC boosted its position in Glaukos Corp. by 126.0% in the second quarter. Lord Abbett & CO. LLC now owns 1,440,111 shares of the company’s stock worth $41,994,000 after buying an additional 802,763 shares during the last quarter. Gilder Gagnon Howe & Co. LLC boosted its position in Glaukos Corp. by 129.3% in the second quarter. Gilder Gagnon Howe & Co. LLC now owns 1,141,840 shares of the company’s stock worth $33,296,000 after buying an additional 643,966 shares during the last quarter. Wellington Management Group LLP bought a new position in Glaukos Corp. during the first quarter worth approximately $10,352,000. Finally, Capital World Investors boosted its position in Glaukos Corp. by 32.6% in the second quarter. Capital World Investors now owns 1,706,070 shares of the company’s stock worth $49,749,000 after buying an additional 419,437 shares during the last quarter. 71.91% of the stock is currently owned by institutional investors.

Glaukos Corp. (NYSE:GKOS) opened at 35.62 on Friday. Glaukos Corp. has a 1-year low of $14.25 and a 1-year high of $39.82. The company has a 50-day moving average of $35.42 and a 200 day moving average of $28.53. The stock’s market cap is $1.18 billion.

Glaukos Corp. (NYSE:GKOS) last announced its earnings results on Monday, August 1st. The company reported $0.06 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.10. Glaukos Corp. had a negative net margin of 1.23% and a negative return on equity of 1.14%. The company had revenue of $28.60 million for the quarter, compared to analysts’ expectations of $24.45 million. During the same quarter in the previous year, the company posted ($1.30) EPS. The firm’s quarterly revenue was up 60.7% on a year-over-year basis. Analysts predict that Glaukos Corp. will post $0.11 EPS for the current year.

Related posts

Leave a Comment